The PRISM study enrollment strategy has been previously published and registered at ClinicalTrials.gov (NCT01789268). 21 Briefly, preterm (<36 weeks of gestation) and term (³37 weeks of gestation) newborns, £7 days of age, born at the University of Rochester Medical Center, Rochester, New York, were eligible for enrollment. Exclusion criteria included airway/chest wall abnormalities, neuromuscular or cardiac disorders (except patent ductus arteriosus or isolated atrial septal defect), genetic disorders of immune system or respiratory function, maternal HIV infection, and nonviability. The Research Subjects Review Board approved the study and all parents provided informed consent. 